Main content

Gene Patenting

A recent US Supreme Court ruling found that companies cannot patent things found in nature. Peter Day asks what this means for the biotech business.

Ever since the mapping of the human genome was completed 10 years ago medical companies have been rushing to patent genes that define all of us for their own exclusive use. Now the US Supreme Court has ruled against patenting things found in nature. Peter Day asks what this means for the biotech business.and for the future of healthcare.

Available now

29 minutes

Last on

Thu 22 Aug 2013 03:32GMT

Contributors to this programme

Μύ

Professor Sir John Burn

Professor of Clinical Genetics, Institute of Genetic Medicine Newcastle University

Μύ

Μύ

David Koepsell

Author, Who Owns You?

Μύ

Julian Hitchcock

Life Science Lawyer, Lawford Davies Denoon

Μύ

Dr Michael Hopkins

Senior Lecturer, University of Sussex

Μύ

Dr Berwyn Clarke

Entrepreneur

Μύ

Dr Hani Gabra

Professor of Medical Oncology, Imperial College London

Μύ

Dr Helen Wallace

Director Genewatch UK

Μύ

Dr Stuart Hogarth

Research Fellow, Kings College London

Μύ

Μύ

Μύ

Broadcasts

  • Sat 17 Aug 2013 01:32GMT
  • Sat 17 Aug 2013 07:32GMT
  • Sun 18 Aug 2013 18:32GMT
  • Wed 21 Aug 2013 14:32GMT
  • Wed 21 Aug 2013 23:32GMT
  • Thu 22 Aug 2013 03:32GMT

Advice For Entrepreneurs

What is the one piece of advice successful global entrepreneurs would offer?

Download this programme

Subscribe to this programme or download individual episodes.